Quest for the right Drug
ורמוקס תרחיף VERMOX SUSPENSION (MEBENDAZOLE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
תרחיף : SUSPENSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Special Warning : אזהרת שימוש
4.4 Special warnings and precautions for use Vermox is not recommended in the treatment of children under 2 years There have been rare reports of reversible liver function disturbances, hepatitis and neutropenia described in patients who were treated with mebendazole at recommended dosages for indicated conditions (see section 4.8 ‘Undesirable effects’). Agranulocytosis and glomerulonephritis have also been reported in patients treated forEchinococcosis. A case-control study of a single outbreak of Stevens-Johnson syndrome /toxic epidermal necrolysis (SJS/TEN) suggested a possible association with the concomitant use of metronidazole with mebendazole. Although there are no additional data on this potential interaction, concomitant use of mebendazole and metronidazole should be avoided. Convulsions in children, including in infants below 1 year of age, have been reported very rarely during post-marketing experience (see section 4.8 ‘Undesirable effects’). Vermox has not been extensively studied in children below the age of 2 years. Therefore, Vermox should be used in children aged 1-2 years only if the potential benefit justifies the potential risk. Because of the lack of sufficient safety data, Vermox should not be used in children below the age of 1 year. Vermox should only be given to very young children if their worm infestation interferes significantly with their nutritional status and physical development. Vermox oral suspension contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. This medicinal product contains less than 1 mmol sodium (23 mg) per mL, that is to say essentially 'sodium-free'.
Effects on Driving
4.7 Effects on ability to drive and use machines Vermox has no influence on the ability to drive and use machines.
שימוש לפי פנקס קופ''ח כללית 1994
Ascariasis, enterobiasis (oxyuriasis), trichuriasis. Ancylostoma, necator, echinococcus granulosus
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף
